Research and Development

Our Group has emerged as one of the reputed processors and exporters of Pharmaceutical Products, owing to our advanced research & development unit. In R&D unit, we have installed the modern testing equipment and machinery which facilitates hygienic processing of our medicines. Further, our professionals constantly involved in research work and bring out innovative ideas to offer superior quality products to the clients. Owing to the research activities of our team of researchers and scientists, we are able to introduce modern techniques to the manufacturing unit. Pharmatech Healthcare is innovative in its manufacturing processes. It has adopted the latest in technology, which has additionally improved on productivity and product quality.

Why Us?
We have secured a distinguished position in the market owing to following factors :

  • Tamper proof packaging
  • Effective range of Pharmaceutical Products
  • Global reach
  • Timely delivery
  • Cost effectiveness
  • State-of-the-art manufacturing unit
  • Diligent team of researchers


Client Satisfaction :
Client satisfaction is one of the major objectives of our organization. Our range of products is widely appreciated and prescribed by various leading physicians and doctors worldwide. Further, our team of dedicated professionals understands the exact needs of clients and delivers the products as per their specifications and requirements. Owing to all such factors, we are well associated with reputed names of the industry and have earned a unique position in the industry.

News Letter

Our mission is to be a leading pharma co in India & the Companys clear business goals are well entrenched amidst our people and each employee is proud to contribute towards the overall mission. We shall provide total customer satisfaction and achieve leadership in chosen markets, products and services through excellence in technology, based on world-class research and development.

18 Dec 2017

 

New products going to launch up very soon in our Robot care section.

18 Dec 2017

 

Readmore..